Predictive efficacy of serum SCC-Ag and VEGF in predicting recurrence during mifepristone treatment in patients undergoing laparoscopic myomectomy: A retrospective cohort study
Pakistan Journal of Pharmaceutical Sciences · 01.02.2027
DOI: 10.36721/pjps/2026.40.16638.1 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, online erschienen am 12.10.2026. Verfasst von Xinru Wang. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Serum squamous cell carcinoma antigen (SCC-Ag) and vascular endothelial growth factor (VEGF) may predict recurrence in patients with uterine fibroids after laparoscopic myomectomy (LM) and mifepristone treatment, but evidence is limited.
Objectives
This retrospective cohort study aimed to evaluate whether preoperative serum SCC-Ag and VEGF levels can predict 2-year recurrence in patients with uterine fibroids receiving postoperative mifepristone after LM.
Objectives
This study aimed to evaluate whether preoperative serum SCC-Ag and VEGF levels can predict 2-year recurrence in UF patients receiving postoperative mifepristone after LM.
Methods
This retrospective study included 110 patients with uterine fibroids who underwent LM followed by 3 months of mifepristone. After a 2-year follow-up, 12 patients (recurrence group) had a recurrence and 98 (non-recurrence group) did not. Serum SCC-Ag, VEGF, estradiol (E2), follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were measured. Logistic regression, ROC analysis, decision curve analysis (DCA) and subgroup analysis were performed.
Results
The recurrence group had significantly higher levels of E2, FSH, LH, SCC-Ag and VEGF (all P
Zitieren
APA
Wang, X. (2027). Predictive efficacy of serum SCC-Ag and VEGF in predicting recurrence during mifepristone treatment in patients undergoing laparoscopic myomectomy: A retrospective cohort study. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps/2026.40.16638.1
Vancouver
Wang X. Predictive efficacy of serum SCC-Ag and VEGF in predicting recurrence during mifepristone treatment in patients undergoing laparoscopic myomectomy: A retrospective cohort study. Pakistan Journal of Pharmaceutical Sciences. 2027. doi:10.36721/pjps/2026.40.16638.1
BibTeX
@article{Wang2027,
author = {Wang, Xinru},
title = {Predictive efficacy of serum SCC-Ag and VEGF in predicting recurrence during mifepristone treatment in patients undergoing laparoscopic myomectomy: A retrospective cohort study},
journal = {Pakistan Journal of Pharmaceutical Sciences},
year = {2027},
doi = {10.36721/pjps/2026.40.16638.1}
}
EUVIMED